Breast Cancer Clinical Trials in Pittsburgh, Pennsylvania

29 studies are recruiting for breast cancer in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

  1. EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

    The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

    Stage
    Not phased
    Ages
    20 to 89
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Run by
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

    See if you can join NCT06115486 on ClinicalTrials.gov

  2. Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

    In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

    Stage
    Not phased
    Ages
    20 to 89
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Run by
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

    See if you can join NCT06858449 on ClinicalTrials.gov

  3. Converting HR+ Breast Cancer Into an Individualized Vaccine

    Newly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer are eligible to a randomized trial, concurrently open at five US academic institutions. Patients receiving 4 months of standard neoadjuvant hormonal therapy with letrozole are randomly assigned to one of 4 arms…

    Stage
    Phase 2
    Ages
    18 to 90
    Site
    UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
    Locations
    8 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT03804944 on ClinicalTrials.gov

  4. MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

    The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enabl…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Allegheny Health Network, Pittsburgh, Pennsylvania
    Locations
    134 in total
    Run by
    Agendia

    See if you can join NCT03053193 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.